See more : Metro Brands Limited (METROBRAND.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Cloud DX Inc. (CDXFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cloud DX Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Global Health Limited (MEDANTA.BO) Income Statement Analysis – Financial Results
- Financiere Hoche Bains-Les-Bains SA (MLHBB.PA) Income Statement Analysis – Financial Results
- Bajaj Auto Limited (BAJAJ-AUTO.NS) Income Statement Analysis – Financial Results
- ADS Maritime Holding Plc (ADS.OL) Income Statement Analysis – Financial Results
- Acrow India Limited (ACROW.BO) Income Statement Analysis – Financial Results
Cloud DX Inc. (CDXFF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.clouddx.com
About Cloud DX Inc.
Cloud DX Inc. operates as a remote patient monitoring company. It offers Cloud DX Connected Health, an end-to-end virtual healthcare platform for monitoring patients with chronic illness, including chronic obstructive pulmonary disease and congestive heart failure, as well as patients recovering from surgery and COVID-19 patients outside hospitals. The company's Cloud DX Connected Health Kits includes its Cloud DX Bluetooth pulse oximeter, the Cloud DX wireless weight scale and optionally, a wireless Bluetooth blood pressure monitor, digital thermometer, and digital wireless glucose meter from 3rd party suppliers. It serves academic institutions, large hospitals, and provincial health authorities in Canada, as well as physician practices and hospitals in the United States. The company also offers VITALITI, a vital sign monitor for measuring electrocardiograph, heart rate, oxygen saturation, respiration, core body temperature, blood pressure, movement, steps, and posture. Cloud DX Inc. is headquartered in Brooklyn, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.81M | 1.17M | 782.30K | 1.16M | 1.25M | 247.77K |
| Cost of Revenue | 529.21K | 563.11K | 491.29K | 732.60K | 228.17K | 127.76K |
| Gross Profit | 1.28M | 602.90K | 291.01K | 431.20K | 1.02M | 120.01K |
| Gross Profit Ratio | 70.79% | 51.71% | 37.20% | 37.05% | 81.76% | 48.44% |
| Research & Development | 192.99K | 397.93K | 473.88K | 550.52K | 252.57K | 317.86K |
| General & Administrative | 6.90M | 9.11M | 9.34M | 5.97M | 842.16K | 1.08M |
| Selling & Marketing | 252.73K | 312.08K | 468.63K | 116.35K | 153.70K | 159.75K |
| SG&A | 7.15M | 9.43M | 9.80M | 6.08M | 287.20K | 6.44M |
| Other Expenses | 1.67M | -18.79K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 9.02M | 9.83M | 9.48M | 5.58M | 287.20K | 7.03M |
| Cost & Expenses | 9.55M | 10.39M | 9.97M | 6.31M | 287.20K | 7.16M |
| Interest Income | 0.00 | 1.60M | 709.40K | 732.23K | 336.99K | 224.11K |
| Interest Expense | 3.37M | 1.60M | 709.40K | 732.23K | 0.00 | 0.00 |
| Depreciation & Amortization | 477.96K | 498.77K | 407.95K | 340.14K | 164.51K | 168.72K |
| EBITDA | -6.93M | -8.79M | -10.24M | -4.74M | -4.40M | -6.82M |
| EBITDA Ratio | -382.42% | -748.52% | -1,122.64% | -412.98% | -22.96% | -2,751.18% |
| Operating Income | -7.74M | -9.72M | -10.42M | -6.55M | -287.20K | -6.99M |
| Operating Income Ratio | -426.90% | -833.54% | -1,332.04% | -562.81% | -22.96% | -2,819.27% |
| Total Other Income/Expenses | -3.04M | -1.17M | -934.58K | 737.73K | -4.68M | -146.18K |
| Income Before Tax | -10.78M | -10.89M | -11.36M | -5.81M | -312.20K | -7.13M |
| Income Before Tax Ratio | -594.93% | -934.04% | -1,451.51% | -499.42% | -24.95% | -2,878.27% |
| Income Tax Expense | -433.91K | -273.89K | -98.22K | 732.31K | -164.51K | 0.00 |
| Net Income | -10.35M | -10.62M | -11.26M | -5.81M | -312.20K | -7.13M |
| Net Income Ratio | -570.99% | -910.55% | -1,438.95% | -499.42% | -24.95% | -2,878.27% |
| EPS | -0.11 | -0.15 | -0.18 | -0.67 | -0.27 | -5.39 |
| EPS Diluted | -0.11 | -0.15 | -0.18 | -0.67 | -0.27 | -5.39 |
| Weighted Avg Shares Out | 93.13M | 72.09M | 64.28M | 8.73M | 1.14M | 1.32M |
| Weighted Avg Shares Out (Dil) | 93.13M | 72.09M | 64.28M | 8.73M | 1.14M | 1.32M |
Cloud DX on track to double sales in 2023 with signing of record-breaking 20th contract
Cloud DX Signs Record-Breaking 20th Contract, on Pace to Double Sales in 2023
Cloud DX Receives Expansion Order from Ontario Heart Centre
Cloud DX expands remote patient monitoring deployment at St. Mary's General Hospital in Kitchener
Cloud DX Signs Remote Patient Monitoring Contract With St. Mary's General Hospital
Cloud DX to raise up to $4M through offering of secured convertible debentures
Cloud DX Announces $4.0 Million Private Placement of Secured Convertible Debentures with Opening Orders for $1.72 Million, Amendments to Existing Secured and Unsecured Convertible Debentures and Warrant Repricing
Cloud DX awarded $3M remote patient monitoring contract
Generative AI to drive MedTech industry growth and innovation with failure to adopt key threat
Cloud DX inks 12th paramedic service contract
Source: https://incomestatements.info
Category: Stock Reports